FDA Advisory Committee Supports Polatuzumab for Previously Untreated Diffuse Large B-cell Lymphoma
March 10th 2023On April 2, 2023, the FDA will announce the approval status of Roche’s supplemental Biologics License Application for polatuzumab in the treatment of diffuse large B-cell lymphoma.
Read More
Social Determinants of Health Can Impact Vaccination Hesitancy, Appointment Adherance
March 9th 2023John E. Clark, PharmD, MS, FASHP, FFSHP, Director, Diversity, Equity, and Inclusion at the Taneja College of Pharmacy, University of South Florida, discusses the importance of addressing social determinants of health to improve patient outcomes.
Watch
Expert: Bi-Enabled Technology in Radiation Oncology Is Shortening Time From Diagnosis to Treatment
March 9th 2023Through automated tools related to scheduling, prior authorization, and radiation planning tasks, there are efforts to shorten the time from diagnosis to treatment to improve patient outcomes.
Watch
Study: Linking Flu Vaccination, Potential Cardiovascular Benefits Increases Vaccination Rates
March 9th 2023Vaccination rates were significantly higher in study groups who received a letter highlighting the potential cardiovascular benefits of vaccination and who received repeat letters about the importance of flu vaccination in general.
Read More